Viatris Inc
VTRS11.930USD
-0.010-0.08%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
13.83BCap. mercado
PérdidaP/E TTM
Más Datos de Viatris Inc Compañía
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Información de Viatris Inc
Símbolo de cotizaciónVTRS
Nombre de la empresaViatris Inc
Fecha de salida a bolsaFeb 01, 1973
Director ejecutivoSmith (Scott A)
Número de empleados32000
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 01
Dirección1000 Mylan Boulevard
CiudadCANONSBURG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal15317
Teléfono17245141465
Sitio Webhttps://www.viatris.com/en
Símbolo de cotizaciónVTRS
Fecha de salida a bolsaFeb 01, 1973
Director ejecutivoSmith (Scott A)
Ejecutivos de Viatris Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Ms. Theodora (Doretta) Mistras
Ms. Theodora (Doretta) Mistras
Chief Financial Officer
Chief Financial Officer
25.18K
--
Ms. JoEllen Lyons Dillon
Ms. JoEllen Lyons Dillon
Independent Director
Independent Director
--
--
Mr. Mark W. Parrish
Mr. Mark W. Parrish
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Melina E. Higgins
Ms. Melina E. Higgins
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Brands
2.28B
64.01%
Generics
1.28B
35.99%
Por regiónUSD
Nombre
Ganancia
Proporción
Developed markets
2.12B
59.38%
Greater China
588.90M
16.50%
Emerging Markets
555.10M
15.55%
JANZ
305.70M
8.57%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Brands
2.28B
64.01%
Generics
1.28B
35.99%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.14%
T. Rowe Price Associates, Inc.
7.13%
Davis Selected Advisers, L.P.
6.02%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.84%
Otro
64.56%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.14%
T. Rowe Price Associates, Inc.
7.13%
Davis Selected Advisers, L.P.
6.02%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.84%
Otro
64.56%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
44.04%
Investment Advisor/Hedge Fund
28.24%
Hedge Fund
8.77%
Research Firm
2.71%
Pension Fund
1.29%
Sovereign Wealth Fund
1.01%
Bank and Trust
0.85%
Individual Investor
0.27%
Family Office
0.06%
Otro
12.75%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1934
987.12M
85.35%
-46.41M
2025Q2
1947
984.91M
83.97%
-87.31M
2025Q1
2006
1.01B
85.93%
-61.76M
2024Q4
2002
1.03B
86.53%
+1.20M
2024Q3
1949
989.28M
82.89%
-66.19M
2024Q2
1967
1.02B
85.33%
-16.59M
2024Q1
1986
997.86M
84.00%
-35.39M
2023Q4
2032
990.53M
82.57%
-31.15M
2023Q3
2044
970.48M
80.90%
-45.34M
2023Q2
2080
963.51M
80.35%
-35.04M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
144.70M
12.41%
+694.66K
+0.48%
Jun 30, 2025
T. Rowe Price Associates, Inc.
76.96M
6.6%
+4.28M
+5.89%
Jun 30, 2025
Davis Selected Advisers, L.P.
66.38M
5.69%
+1.43M
+2.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
61.38M
5.26%
-2.94M
-4.57%
Jun 30, 2025
State Street Investment Management (US)
55.29M
4.74%
-6.17M
-10.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
31.26M
2.68%
+10.00M
+47.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
31.23M
2.68%
+52.78K
+0.17%
Jun 30, 2025
Columbia Threadneedle Investments (US)
22.77M
1.95%
+1.16M
+5.38%
Jun 30, 2025
Deerfield Management Company, L.P.
24.02M
2.06%
+32.31K
+0.13%
Jun 30, 2025
Invesco Capital Management LLC
24.15M
2.07%
+928.68K
+4.00%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Pharmaceuticals ETF
4.46%
First Trust NASDAQ Pharmaceuticals ETF
3.81%
Davis Select Worldwide ETF
3.62%
Davis Select US Equity ETF
3.36%
Invesco Pharmaceuticals ETF
2.66%
State Street SPDR S&P Pharmaceuticals ETF
2.64%
Invesco S&P Ultra Dividend Revenue ETF
2.56%
Alps Sector Dividend Dogs ETF
2.1%
AAM S&P 500 High Dividend Value ETF
1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.88%
Ver más
iShares U.S. Pharmaceuticals ETF
Proporción4.46%
First Trust NASDAQ Pharmaceuticals ETF
Proporción3.81%
Davis Select Worldwide ETF
Proporción3.62%
Davis Select US Equity ETF
Proporción3.36%
Invesco Pharmaceuticals ETF
Proporción2.66%
State Street SPDR S&P Pharmaceuticals ETF
Proporción2.64%
Invesco S&P Ultra Dividend Revenue ETF
Proporción2.56%
Alps Sector Dividend Dogs ETF
Proporción2.1%
AAM S&P 500 High Dividend Value ETF
Proporción1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.88%
Dividendos
Un total de
2.13B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 04, 2025
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2025 going ex on Nov 24, 2025
Nov 24, 2025
Dec 15, 2025
Nov 24, 2025
Aug 05, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2025 going ex on Aug 22, 2025
Aug 22, 2025
Sep 15, 2025
Aug 22, 2025
May 07, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 16, 2025 going ex on May 23, 2025
May 23, 2025
Jun 16, 2025
May 23, 2025
Feb 27, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 18, 2025
Mar 10, 2025
Nov 05, 2024
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 13, 2024 going ex on Nov 22, 2024
Nov 22, 2024
Dec 13, 2024
Nov 22, 2024
Aug 06, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 13, 2024 going ex on Aug 23, 2024
Aug 23, 2024
Sep 13, 2024
Aug 23, 2024
May 09, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 14, 2024 going ex on May 23, 2024
May 24, 2024
Jun 14, 2024
May 23, 2024
Feb 28, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2024 going ex on Mar 08, 2024
Mar 11, 2024
Mar 18, 2024
Mar 08, 2024
Nov 08, 2023
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2023 going ex on Nov 22, 2023
Nov 24, 2023
Dec 15, 2023
Nov 22, 2023
Aug 07, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2023 going ex on Aug 23, 2023
Aug 24, 2023
Sep 15, 2023
Aug 23, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Viatris Inc?
Los cinco principales accionistas de Viatris Inc son:
The Vanguard Group, Inc. posee 144.70M acciones, lo que representa el 12.41% del total de acciones.
T. Rowe Price Associates, Inc. posee 76.96M acciones, lo que representa el 6.60% del total de acciones.
Davis Selected Advisers, L.P. posee 66.38M acciones, lo que representa el 5.69% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 61.38M acciones, lo que representa el 5.26% del total de acciones.
State Street Investment Management (US) posee 55.29M acciones, lo que representa el 4.74% del total de acciones.
The Vanguard Group, Inc. posee 144.70M acciones, lo que representa el 12.41% del total de acciones.
T. Rowe Price Associates, Inc. posee 76.96M acciones, lo que representa el 6.60% del total de acciones.
Davis Selected Advisers, L.P. posee 66.38M acciones, lo que representa el 5.69% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 61.38M acciones, lo que representa el 5.26% del total de acciones.
State Street Investment Management (US) posee 55.29M acciones, lo que representa el 4.74% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Viatris Inc?
Los tres principales tipos de accionista de Viatris Inc son:
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Davis Selected Advisers, L.P.
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Davis Selected Advisers, L.P.
¿Cuántas instituciones poseen acciones de Viatris Inc (VTRS)?
A fecha de 2025Q3, 1934 instituciones poseen acciones de Viatris Inc, con un valor de mercado combinado de aproximadamente 987.12M, lo que representa el 85.35% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 1.37%.
¿Cuál es la mayor fuente de ganancias de Viatris Inc?
El FY2025Q2, el segmento empresarial Brands generó la ganancia más alta para Viatris Inc, ascendiendo a 2.28B y representando el 64.01% de la ganancia total.
